This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Duke Energy, Progress: Premarket Trading

NEW YORK ( TheStreet) -- Duke Energy (DUK) and competitor Progress Energy (PGN) will merge in a stock-for-stock transaction resulting in an energy company with a market capitalization of $37 billion.

Under the deal, Duke will buy Progress Energy for $13.7 billion, or $46.48 a share. Duke Energy also will assume about $12.2 billion in debt of Progress Energy.

The transaction price represents a 7.1% premium to the closing stock price of Progress Energy on Jan. 5 and a 3.9% premium to the closing stock price of Progress Energy on Jan. 7.

Shares of Duke Energy fell 0.9% to $17.63 in premarket trading Monday, and Progress shares were down 1.1% to $44.25.

DuPont( DD ) agreed to buy Danisco, the Danish food ingredients company, for $5.8 billion in cash and the assumption of $500 million of Danisco debt.

Shares of DuPont fell 0.2% to $49.65.

Johnson & Johnson (JNJ) approached European medical device maker Smith & Nephew (SNN) with a takeover bid last month, according to reports.

Shares of J&J were flat at $62.60 in premarket trading, while Smith & Nephew surged by 11.8% to $56.81.

Over the weekend, BP (BP) said it was shutting down 95% of its Alaskan oil production because of an oil leak at a pump station on the North Slope, according to reports.

BP shares fell 2.3% to $45.03 in premarket trading.

IT provider iGate (IGTE) agreed to acquire a majority stake in Patni Computer Systems (PTI).

There were no premarket trades for iGate. Shares of the company ended Friday's trading session at $19.16, down 1.5%. Patni rose by 3.2% to $21.40 in premarket trading Monday.

Alcoa (AA) is expected to release fourth-quarter earnings after the market closes Monday. It's the first Dow component scheduled to release its numbers.

Alcoa rose 0.7% to $16.54.

Citing people familiar with the situation, the Wall Street Journal said Genzyme (GENZ) is once again talking to Sanofi Aventis (SNY) about a potential merger.

Genzyme stock was up 3.5% to $73.85 in premarket trading Monday, while Sanofi Aventis fell 2.2% to $31.50.

There is speculation that Verizon Communications (VZ) plans to hold an event in New York this week to announce its plans to begin selling Apple's (AAPL) iPhone, news that will officially end AT&T's (T) exclusivity with the device.

Verizon's stock was up 1.5% to $36.47, while shares of AT&T were flat at $28.85. Apple shares rose 0.7% to $338.49.

>>Search for Highest Dividends by Rate or Yield
More on Earnings
Today's Top Earnings
Earnings Calendar

-- Written by Andrea Tse in New York.

>To contact the writer of this article, click here: Andrea Tse.

>To follow the writer on Twitter, go to Andrea Tse.

>To submit a news tip, send an email to:


Copyright 2010 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.30 -0.92%
FB $118.22 0.67%
GOOG $699.64 1.10%
TSLA $229.30 -1.30%
YHOO $36.00 -0.03%


Chart of I:DJI
DOW 17,659.14 -91.77 -0.52%
S&P 500 2,050.11 -13.26 -0.64%
NASDAQ 4,727.0990 -36.1250 -0.76%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs